Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions
NCT00778544
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
amoxicillin-clavulanic acid 600 mg- 42.9 mg/ 5 mL oral suspension
Sponsor
Ranbaxy Laboratories Limited